Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001140361-17-015051
Filing Date
2017-04-06
Accepted
2017-04-05 19:47:19
Documents
1
Effectiveness Date
2017-04-06
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 5957
  Complete submission text file 0001140361-17-015051.txt   6992
Mailing Address 2125 EAST MALL, SUITE 305 VANCOUVER A1 V6T 1Z4
Business Address 2125 EAST MALL, SUITE 305 VANCOUVER A1 V6T 1Z4 (604) 827-2128
AbCellera Biologics Inc. (Filer) CIK: 0001703057 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-284172 | Film No.: 17744104